1. Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer. 2009; 115:3379–3391. PMID:
19484787.
2. Marchesi F, Piemonti L, Montovani A, Allavena P. Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis. Cytokine Growth Factor Rev. 2010; 21:77–82. PMID:
20060768.
Article
3. D'Amico AV, Wu Y, Chen MH, Nash M, Renshaw AA, Richie JP. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer. J Urol. 2001; 165:126–129. PMID:
11125380.
4. Freedland SJ, Csathy GS, Dorey F, Aronson WJ. Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol. 2002; 167:516–520. PMID:
11792909.
Article
5. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol. 1974; 111:58–64. PMID:
4813554.
Article
6. Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol. 2009; 27:5131–5137. PMID:
19738119.
Article
7. Ha HK, Yun CJ, Lee SS, Shin DG, Lee W, Lee ZZ, et al. Survival rates and related factors in men with hormone-refractory prostate cancer. Korean J Urol. 2009; 50:649–655.
Article
8. Loeb S, Epstein JI, Humphreys EB, Walsh PC. Does perineural invasion on prostate biopsy predict adverse prostatectomy outcomes? BJU Int. 2010; 105:1510–1513. PMID:
19694710.
Article
9. Ravery V, Boccon-Gibod LA, Dauge-Geffroy MC, Billebaud T, Delmas V, Meulemans A, et al. Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology. 1994; 44:371–376. PMID:
7521093.
Article
10. Endrizzi J, Seay T. The relationship between early biochemical failure and perineural invasion in pathological T2 prostate cancer. BJU Int. 2000; 85:696–698. PMID:
10759668.
Article
11. Ozcan F. Correlation of perineural invasion on radical prostatectomy specimens with other pathologic prognostic factors and PSA failure. Eur Urol. 2001; 40:308–312. PMID:
11684847.
Article
12. Ng JC, Koch MO, Daggy JK, Cheng L. Perineural invasion in radical prostatectomy specimens: lack of prognostic significance. J Urol. 2004; 172:2249–2251. PMID:
15538241.
Article
13. Quinn DI, Henshall SM, Brenner PC, Kooner R, Golovsky D, O'Neill GF, et al. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion. Cancer. 2003; 97:1884–1893. PMID:
12673714.
14. Lee IH, Roberts R, Shah RB, Wojno KJ, Wei JT, Sandler HM. Perineural invasion is a marker for pathologically advanced disease in localized prostate cancer. Int J Radiat Oncol Biol Phys. 2007; 68:1059–1064. PMID:
17398032.
Article
15. Jeon HG, Bae J, Yi JS, Hwang IS, Lee SE, Lee E. Perineural invasion is a prognostic factor for biochemical failure after radical prostatectomy. Int J Urol. 2009; 16:682–686. PMID:
19602004.
Article
16. Stone NN, Stock RG, Parikh D, Yeghiayan P, Unger P. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate. J Urol. 1998; 160:1722–1726. PMID:
9783940.
Article
17. Miyake H, Sakai I, Harada K, Eto H, Hara I. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer. Hinyokika Kiyo. 2005; 51:241–246. PMID:
15912782.
18. Merrilees AD, Bethwaite PB, Russell GL, Robinson RG, Delahunt B. Parameters of perineural invasion in radical prostatectomy specimens lack prognostic significance. Mod Pathol. 2008; 21:1095–1100. PMID:
18500264.
Article